RECORDATI RARE DISEASES

DelveInsight's report on Neurotrophic Keratitis Market (2020-2034) covers epidemiology, market trends, key companies (Oyster Point Pharma, Recordati Rare Diseases, MimeTech, Claris Biotherapeutics, ReGenTree, BRIM Biotechnology), therapies (OC-01, REC 0559, CSB-001, RGN-259, BRM424, cenegermin-bkbj, Udonitrectag, RGN-259), and market dynamics in the US, EU4, UK, and Japan.